KR890002227A - 특이적으로 결합가능한 단백질 물질의 측정 방법 - Google Patents

특이적으로 결합가능한 단백질 물질의 측정 방법 Download PDF

Info

Publication number
KR890002227A
KR890002227A KR870013351A KR870013351A KR890002227A KR 890002227 A KR890002227 A KR 890002227A KR 870013351 A KR870013351 A KR 870013351A KR 870013351 A KR870013351 A KR 870013351A KR 890002227 A KR890002227 A KR 890002227A
Authority
KR
South Korea
Prior art keywords
protein
specifically bindable
molecular weight
carrier material
solid phase
Prior art date
Application number
KR870013351A
Other languages
English (en)
Other versions
KR910002543B1 (ko
Inventor
빌헬름 티숴 데에르
마이어 조세프
데그 데에르.롤프
Original Assignee
데에르. 다움·데에르. 포우크에트
뵈링거 만하임 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데에르. 다움·데에르. 포우크에트, 뵈링거 만하임 게엠베하 filed Critical 데에르. 다움·데에르. 포우크에트
Publication of KR890002227A publication Critical patent/KR890002227A/ko
Application granted granted Critical
Publication of KR910002543B1 publication Critical patent/KR910002543B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Press Drives And Press Lines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

특이적으로 결합가능한 단백질 물질의 측정 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 교차 결합되지 않은 Fab<TSH>(커브 1), 교차결합된 Fab<TSH>(커브 2), Fab<TSH>/β-Gal의 결합체(커브 3) 및 Fab<TSH>써모(thermo)-BSA(커브 4)를 사용함으로써 TSH를 측정하는 캘리브래이션(calibration)커브이다.
제2도는 고정화 스트랩타비딘 및 비오티닐화 AK<TSH>, 교차결합되지 않은 스트랩타비딘(커브 1), 교차결합된 스트랩타비딘(커브 2), 스트랩타비딘/β -gal결합체(커브 3), 스트랩타비딘/BSA 결합체(커브 4), 스트랩타비닌/써모 -BSA 결합체(커브 P/5) 및 스트랩타비딘/써모-BSA 결합체(커브6)FMF 사용함으로써 TSH을 측정하는 캘리브레이션 커브이다.

Claims (15)

  1. 특이적으로 결합가능한 물질보다 더 소수성이며 약 500,000이상의 분자량을 지니는 가용성 단백질이 특이적으로 결합 가능한 물질에 결합되고 반응 성분과 단백질의 결합제가 소수성 고체상에 흡착되고, 특히 면역 검정 원리에 따라 이종 분석 방법에 사용하는, 불용성 담체 물질에 결합된 특이적으로 결합 가능한 단백질 물질의 제조방법.
  2. 제1항에 있어서, 가용성 단백질로서 500,000-20밀리온의 분자량을 지니는 단백질이 사용되는 방법.
  3. 제2항에 있어서, 가용성 단백질이 10,000-70,000분자량의 단백질로부터 분자량을 500,000-20밀리온까지 증가시킴에 의해 제조되는 방법.
  4. 전기한 항의 어느 한 항에 있어서, 결합전에 단백질이 이기능 또는 다기능 단백질 시약으로 원하는 분자량을 얻을 때까지 교차 결합되는 방법.
  5. 전기한 항의 어느 한 항에 있어서, 소수성화(hydrophobed)단백질이 사용되는 방법.
  6. 제5항에 있어서, 결합전에 단백질이 열을 사용해 산, 변성제 또는 캐오트로픽 이온으로 처리함에 의해 및/또는 소수서 화합물과 화학적으로 결합함에 의해 소수성 화되는 방법.
  7. 제4항에 있어서, 다숙신이미딜 수버레이트가 이기능 화합물로서 사용되는 방법.
  8. 제3항 내지 제7항의 어느 한 항에 있어서, 소의 혈청 알부민, 리파제 및/또는 면역 r-글로블린이 단백질로서 사용되는 방법.
  9. 제1항 내지 제8항의 어느 한 항의 방법으로 제조된, 불용성 담체 물질에 결합된 특이적으로 결합가능한 단백질.
  10. 약 500,000이상의 분자량을 갖는 소수성 단백질 및 특이적으로 결합가능한 단백질 물질의 결합체가 흉착되는 소수성 고체상으로 구성되는 제1항 내지 제8항의 어느 한 항에 따라 제조된 고체상 면역검정에 사용되는 담체 물질.
  11. 제19항에 있어서, 소수성 고체상이 폴리스티렌, 폴리메트아크릴레이트, 폴리아미드, 폴리테트라플루오로에틸렌 또는 스트렌과 아크릴로니트릴의 공중합체로 구성되는 담체 물질.
  12. 제10항 또는 제11항에 있어서, 단백질이 소수성화된 소의 혈청 알부민(써모-BSA), 소수성화된 리파제 또는 소수성화된 면역 r-글로블린인 담체 물질.
  13. 제10항 내지 제12항의 어느 한 항에 있어서, 특이적으로 결합가능한 물질이 항원 또는 항체인 담체 물질.
  14. 제10항 내지 제12항의 어느 한 항에 있어서, 특이적으로 결합가능한 물질이 스트랩타비딘 또는 아비딘인 담체 물질.
  15. 제10항 내지 제14항의 어느 한 항에 있어서, 담체가 양모상 유리섬유 또는 셀룰로스-/셀룰로스 에스테르 섬유 및 중합체 섬유로부터의 양모상 섬유인 담체 물질.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870013351A 1986-11-26 1987-11-26 특이적으로 결합가능한 단백질 물질의 측정방법 KR910002543B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863640412 DE3640412A1 (de) 1986-11-26 1986-11-26 Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
DEP3640412.8 1986-11-26

Publications (2)

Publication Number Publication Date
KR890002227A true KR890002227A (ko) 1989-04-10
KR910002543B1 KR910002543B1 (ko) 1991-04-23

Family

ID=6314821

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870013351A KR910002543B1 (ko) 1986-11-26 1987-11-26 특이적으로 결합가능한 단백질 물질의 측정방법

Country Status (13)

Country Link
US (1) US5061640A (ko)
EP (1) EP0269092B1 (ko)
JP (1) JPH0731205B2 (ko)
KR (1) KR910002543B1 (ko)
CN (1) CN1032164C (ko)
AT (1) ATE86743T1 (ko)
AU (1) AU592910B2 (ko)
CA (1) CA1302245C (ko)
DD (1) DD279741A5 (ko)
DE (2) DE3640412A1 (ko)
ES (1) ES2054648T3 (ko)
GR (1) GR3007910T3 (ko)
ZA (1) ZA878824B (ko)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725504A1 (de) * 1987-07-31 1989-02-09 Thraenhart Olaf Priv Doz Dr Verfahren und vorrichtung zum nachweis von antikoerpern und antigenen
DE3806431A1 (de) * 1988-02-29 1989-09-07 Boehringer Mannheim Gmbh Verfahren zur herstellung einer festphasenmatrix
US5268306A (en) * 1988-02-29 1993-12-07 Boehringer Mannheim Gmbh Preparation of a solid phase matrix containing a bound specific binding pair
IE64286B1 (en) * 1988-05-25 1995-07-26 Boehringer Mannheim Gmbh Process for the determination of an immunologically detectable substance and a suitable vessel therefor
US5362624A (en) * 1988-05-25 1994-11-08 Boehringer Mannheim Gmbh Process for the determination of an immunologically detectable substance and a suitable reaction vessel therefor
DE3901638C2 (de) * 1988-05-25 1999-03-25 Roche Diagnostics Gmbh Verfahren zur Bestimmung einer immunologisch nachweisbaren Substanz und dazu geeignetes Reaktionsgefäß
US5888728A (en) 1988-10-17 1999-03-30 Molecular Devices Corporation Hapten derivatized capture membrane and diagnostic assays using such membrane
DE3842700A1 (de) * 1988-12-19 1990-06-21 Boehringer Mannheim Gmbh Verfahren zur proteinimmobilisierung an einer festphase, so hergestellte protein tragende festphase sowie deren verwendung
US6333397B1 (en) 1989-04-25 2001-12-25 Roche Diagnostics Gmbh Monoclonal antibodies to troponin T and their production
DE3922873A1 (de) * 1989-04-25 1990-10-31 Boehringer Mannheim Gmbh Spezifische antikoerper gegen troponin t, ihre herstellung und verwendung in einem reagenz zur bestimmung von hermuskelnekrosen
DE3915135A1 (de) * 1989-05-09 1990-11-15 Boehringer Mannheim Gmbh Verfahren zum nachweis spezifisch bindefaehiger substanzen in koerperfluessigkeiten
US5270193A (en) * 1989-10-27 1993-12-14 E. I. Dupont De Nemours And Company Immobilization of biomolecules on perfluorocarbon surfaces
GB8927230D0 (en) * 1989-12-01 1990-01-31 Unilever Plc Reagents
DE3942999C2 (de) * 1989-12-27 1997-12-18 Progen Biotechnik Gmbh Verfahren zum Nachweis von malignen Erkrankungen
DE4024544A1 (de) * 1990-08-02 1992-02-06 Boehringer Mannheim Gmbh Analyseelement und verfahren zu seiner herstellung
DE4025726A1 (de) 1990-08-14 1992-02-20 Boehringer Mannheim Gmbh Bestimmung von biogenen aminen
WO1992003732A2 (en) * 1990-08-28 1992-03-05 Bioprobe International, Inc. Compositions and methods for enhanced binding in biological assays
JPH04363659A (ja) * 1991-06-10 1992-12-16 Smithkline Beckman Corp ビタミンｂ１２の分析
WO1992022816A1 (en) * 1991-06-11 1992-12-23 Csl Limited Solid phase immunoassay
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
DE4202850A1 (de) * 1992-01-31 1993-08-05 Boehringer Mannheim Gmbh Analysenelement fuer immunoassays
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
DE4312399A1 (de) * 1993-04-16 1994-10-20 Boehringer Mannheim Gmbh Verfahren zur Bestimmung der Bindung eines Transkriptionsfaktors an eine Nukleinsäure
DE4313975A1 (de) * 1993-04-28 1994-11-03 Cytech Biomedical Inc Immunisierungsmittel und Affinitätschromatographie-Trägermaterial
DE4343480A1 (de) * 1993-12-21 1995-07-06 Boehringer Mannheim Gmbh Acylierte Proteinaggregate und deren Verwendung zur Signalsteigerung in einem Immunoassay zum Nachweis von Antikörpern
DE4343479A1 (de) * 1993-12-21 1995-06-22 Boehringer Mannheim Gmbh Acylierte Proteinaggregate und deren Verwendung zur Entstörung von Immunoassays
DE19637718A1 (de) 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Rekombinante inaktive Core-Streptavidin Mutanten
DE19724787A1 (de) * 1997-06-06 1998-12-10 Biotez Berlin Buch Gmbh Bioche Streptavidin/Avidin beschichtete Oberflächen
US6033918A (en) * 1997-11-10 2000-03-07 Bayer Corporation Method and device for the detection of analyte in a fluid sample
DE19924643B4 (de) * 1999-05-28 2017-02-23 Roche Diagnostics Gmbh Verfahren zur Herstellung von Protein-beladenen Mikropartikeln
CA2452208C (en) * 2001-08-10 2010-01-26 F. Hoffmann-La Roche Ag Method for producing microparticles loaded with proteins
JP5476376B2 (ja) * 2008-07-16 2014-04-23 ラジオメーター・メディカル・アー・ペー・エス 高性能固相
GB201105828D0 (en) 2011-04-06 2011-05-18 Vivacta Ltd A device for detecting an analyte
GB201121269D0 (en) 2011-12-12 2012-01-25 Vivacta Ltd A method forblood measurement
JP5717658B2 (ja) * 2012-01-13 2015-05-13 シスメックス株式会社 副腎皮質刺激ホルモンの検出方法および吸着剤
EP3274724A1 (en) 2015-03-25 2018-01-31 Alexion Pharmaceuticals, Inc. A method for measuring the protease activity of factor d of the alternative complement pathway
WO2016151557A1 (en) 2015-03-25 2016-09-29 Alexion Pharmaceuticals, Inc. A method for measuring the protease activity of c5 convertase of the alternative complement pathway
CN109154617B (zh) 2016-05-31 2022-08-26 豪夫迈·罗氏有限公司 用于hcv核心抗原的快速检测的预处理方法
EP3465217A1 (en) 2016-05-31 2019-04-10 Roche Diagnostics GmbH Method for serological detection of viral antigens
ES2865511T3 (es) 2017-02-02 2021-10-15 Hoffmann La Roche Inmunoanálisis que usa al menos dos agentes de unión específica a analito pegilado
KR20200032695A (ko) 2017-07-27 2020-03-26 에프. 호프만-라 로슈 아게 Hcv 항원의 다중-에피토프 융합 단백질 및 이의 용도
CN113030456A (zh) * 2021-04-02 2021-06-25 山东康华生物医疗科技股份有限公司 一种抗环瓜氨酸肽抗体的检测试纸条、检测卡及试剂盒

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006059A (en) * 1974-07-29 1977-02-01 Purdue Research Foundation Hydrophobic noncovalent binding of proteins to support materials
US3966580A (en) * 1974-09-16 1976-06-29 The University Of Utah Novel protein-immobilizing hydrophobic polymeric membrane, process for producing same and apparatus employing same
US4069352A (en) * 1976-07-02 1978-01-17 Baxter Travenol Laboratories, Inc. Immunoadsorbent polymeric material and method of making same
US4210418A (en) * 1976-08-30 1980-07-01 Mallinckrodt, Inc. Container for immunochemical and enzymatical determinations or procedures
AU533026B2 (en) * 1979-10-26 1983-10-27 Dynasciences Corp. Passively adsorbing immuno-reactive haptens to solid phases
SE8003732L (sv) * 1980-05-19 1981-11-20 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
DE3116491A1 (de) * 1981-04-25 1982-11-11 Basf Ag, 6700 Ludwigshafen "thermoplastische formmassen"
JPS5861466A (ja) * 1981-10-08 1983-04-12 Yatoron:Kk 血清学的凝集反応による測定方法
US4606855A (en) * 1982-07-26 1986-08-19 Mex Research Associates C/O Leon Reimer Monoclonal antibody to digoxin
US4572901A (en) * 1983-06-23 1986-02-25 Children's Hospital Medical Center Of Northern California Method and composition for protein immobilization
EP0142192A1 (en) * 1983-10-22 1985-05-22 Akzo N.V. Preparation of immunogens consisting of antigenic determinates bound to glycoside-containing carriers
JPS62132172A (ja) * 1985-12-04 1987-06-15 Shionogi & Co Ltd 固相化抗体およびその製造方法
US4808530A (en) * 1986-09-05 1989-02-28 The Ohio State University Protein immobilization by adsorption of a hydrophobic amidine protein derivative to a hydrophobic surface

Also Published As

Publication number Publication date
US5061640A (en) 1991-10-29
DE3784638D1 (de) 1993-04-15
DD279741A5 (de) 1990-06-13
ES2054648T3 (es) 1994-08-16
CN1032164C (zh) 1996-06-26
KR910002543B1 (ko) 1991-04-23
DE3640412A1 (de) 1988-06-09
EP0269092A2 (de) 1988-06-01
CN87107982A (zh) 1988-06-15
AU592910B2 (en) 1990-01-25
GR3007910T3 (ko) 1993-08-31
ATE86743T1 (de) 1993-03-15
JPH0731205B2 (ja) 1995-04-10
EP0269092A3 (en) 1990-01-24
EP0269092B1 (de) 1993-03-10
CA1302245C (en) 1992-06-02
ZA878824B (en) 1989-04-26
AU8169587A (en) 1988-06-02
JPS63142268A (ja) 1988-06-14

Similar Documents

Publication Publication Date Title
KR890002227A (ko) 특이적으로 결합가능한 단백질 물질의 측정 방법
EP0303110B1 (en) Immunodiagnostic device and method
CA1338928C (en) Ion capture assays and devices
US6114180A (en) Synthetic calibrators for use in immunoassays, comprising the analytes or partial sequences thereof which are conjugated to inert carrier molecules
CA2224674A1 (en) Immunoassay and kit with two reagents that are cross-linked if they adhere to an analyte
ES2047749T3 (es) Procedimiento para la deteccion de sustancias capaces de fijarse especificamente en liquidos corporales.
ATE421692T1 (de) Polyethylenglykol-derivatisierte biomoleküle und deren verwendung in heterogenen nachweisverfahren
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
EP0064318B1 (en) A method and a kit for the assay of antibodies to soluble antigens
JPH1026621A (ja) イムノアッセイ法
GB2175906A (en) Assay methods and reagents
JP3267614B2 (ja) カルボキシメチルアミロースに結合させた結合メンバーを使用するイオン捕獲アッセイ
ES8503855A1 (es) Procedimiento de inmunoanalisis homogeneo para determinar un analito en una muestra de ensayo.
CN116930489A (zh) 层析试纸条、检测试剂盒及方法
JP4984080B2 (ja) 免疫化学反応のシグナル増強剤および免疫学的測定方法
CA1234044A (en) Specific binding assay reagent
CA2149062C (en) Immunoassays using a carbon sol label
AU8630898A (en) Antibodies and other binding molecules specific for hepatitis b viral antigens
JPH08136496A (ja) バイオセンサー
ES2056041T1 (es) Procedimiento para la determinacion de anticuerpos y antigenos.
KR910008704B1 (ko) 면역학적으로 검출 가능한 물질의 측정 방법 및 이것에 적당한 반응 용기
WO2001077182A1 (fr) Complexe anticorps-porteur, procede de production, methode de controle de la reaction antigene-anticorps par ledit complexe et procede de dosage immunologique
JPH06341990A (ja) 抗原又は抗体固定化プレート及びそれを用いた免疫測定法
WO1994003807A1 (en) Separation method
Stoner ENZYME AFFINITY ASSAY-A NEW METHOD FOR THE QUANTITATION OF HISTAMINE.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19960416

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee